Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Milk vs. factory fats: which is worse for your heart?

NCT ID NCT00439582

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how two types of trans fats—one from milk and one from processed oils—affect heart disease risk. 46 healthy adults ate special foods containing either type of fat for a period, and researchers measured changes in their cholesterol and other blood markers. The goal was to see if natural trans fats are less harmful than industrial ones.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

46 people

Start date

Aug 2005

Completion date

Dec 2005

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * HDL cholesterol, g/L \> 0.4 * Triacylglycerol g/L \<1.50 * LDL Cholesterol g/L \<1.60 * Affiliated to National Health Insurance * Waist size \< 102 cm (men) or 88 cm (women) * Normal blood pressure (diastolic \<90 mm Hg, systolic \<140 mm Hg) * Normal liver functions (γ-GT, transaminases, alkaline phosphatase) * Normal white blood cells count (4-10 g/L) * For women: effective contraception * Subject giving his/her written informed consent * Subject willing to comply with the study procedures * Subject considered as normal after clinical examination and medical questionnaire Exclusion Criteria: * Reported food allergies * Currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of this study * Hepatic or renal impairments * Positive serologies to HIV or HCV, determined on blood sample * For women, pregnant or presently attempting to get pregnant (-HCG blood test) or menopause or lactating * Blood donation done less than 2 months before the start of the study * Chronic pathologies: diabetes (fasted glycaemia \> 6,1 mmol/L), hypertriglyceridemia (≥1.50 g/L), hypertension (systolic blood pressure ≥ 140 mm Hg and/or diastolic blood pressure ≥ 90 mm Hg), cardiovascular diseases, chronic inflammatory diseases * Intestine, cardiovascular, kidney and cancer pathologies in the last 5 years * Previous heavy intestine surgery (except appendicectomy) * Previous medical and/or surgery judged by the investigator as incompatible with this study * High variation (\> 5%) of body weight during the last 3 months * Consuming nutritional supplements which could interfered with lipid metabolism (fish oil capsule, vitamins, soja lecithins,…) * Heavy consumer of alcohol (evaluated thanks to the values of the following hepatic enzymes: -GT, ASAT, ALAT) * Smoker or ex-smoker who stopped smoking less than 1 month before V0 * Practicing intensive physical exercise (\> 3 h per week) * Vegetarian or vegan * Taking medication for depressive or psychiatric state * Being under someone's supervision * Refusal to be registered on the National Volunteers Data file * Disliking butter, margarine, cheese, biscuits and/or vegetable oil * Dietary habits unreliable to controlled food intake * Being in exclusion on the National Volunteers Data file

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre de Recherche en Nutrition Humaine (CRNH), UEN, Laboratoire de Nutrition Humaine

    Clermont-Ferrand, 63009, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.